Alessandrino, Francesco
Sahu, Sonia
Nishino, Mizuki
Adeni, Anika E.
Tirumani, Sree Harsha
Shinagare, Atul B.
Awad, Mark M.
Article History
First Online: 21 February 2019
Compliance with ethical standards
:
: Francesco Alessandrino, MD: no conflict of interests. Sonia Sahu, MD: no conflict of interests. Mizuki Nishino MD, MPH Consultant to Bristol-Myers Squibb, Toshiba Medical Systems, WorldCare Clinical, Daiichi Sankyo; Research grant from Merck Investigator Studies Program, Toshiba Medical Systems, AstraZeneca; Honorarium from Bayer and Roche. The investigator, M.N., was supported by 1R01CA203636 (NCI). Anika E. Adeni: no conflict of interests. Sree Harsha Tirumani, MD: no conflict of interests. Atul B. Shinagare, MD: Consultant, Arog Pharmaceuticals. Mark Awad, MD, PhD: Consultant Bristol-Myers Squibb, Merck, Genentech, AstraZeneca. Research funding from Bristol-Myers Squibb.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.